Lack of Association between Unexplained Elevated Maternal Serum Alpha Fetoprotein and/or Human Chorionic Gonadotropin and the Occurrence of Placental Thrombotic Lesions

Placenta

Volumn 31, Issue 4, 2010, Pages 277-281

  Salim, R ^a,b   Okopnik, M ^a   Garmi, G ^a   Nachum, Z ^a,b   Zafran, N ^a   Shalev, E ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Alpha fetoprotein; Human chorionic gonadotropin; Placental thrombotic lesions

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ANTEPARTUM HEMORRHAGE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; FEMALE; GONADOTROPIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA DISORDER; PLACENTAL DELIVERY; PLACENTAL THROMBOTIC LESION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TERM BIRTH; THROMBOSIS;

ADULT; ALPHA-FETOPROTEINS; BODY MASS INDEX; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOSIS;

EID: 77950370942     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.01.010     Document Type: Article

References (28)

1. Yaron Y., Cherry M., Kramer R.L., O'Brien J.E., Hallak M., Johnson M.P., et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 181 (1999) 968-974
2. Chandra S., Scott H., Dodds L., Watts C., Blight C., and Van Den Hof M. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 189 (2003) 775-781
3. Dugoff L., Hobbins J.C., Malone F.D., Vidaver J., Sullivan L., Canick J.A., et al. FASTER trial research Consortium. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106 (2005) 260-267
4. Caughey A.B., Stotland N.E., and Escobar G.J. What is the best measure of maternal complications of term pregnancy: ongoing pregnancies or pregnancies delivered?. Am J Obstet Gynecol 189 (2003) 1047-1052
5. Waller D.K., Lustig L.S., Cunningham G.C., Golbus M.S., and Hook E.B. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 325 (1991) 6-10
6. Hossain N., and Paidas M.J. Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies. Semin Perinatol 31 (2007) 208-212
7. Younis J.S., and Samueloff A. Gestational vascular complications. Best Pract Res Clin Haematol 16 (2003) 135-151
8. Leiberman J.R., Fraser D., Weitzman S., and Glezerman M. Birthweight curves in southern Israel populations. Isr J Med Sci 29 (1993) 198-203
9. Mousa H.A., and Alfirevic1 Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Humanit Rep 15 (2000) 1830-1833
10. Redline R.W., Ariel I., Baergen R.N., Desa D.J., Kraus F.T., Roberts D.J., et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 7 (2004) 443-452
11. Redline R.W., Boyd T., Campbell V., Hyde S., Kaplan C., Khong T.Y., et al. Society for pediatric pathology, perinatal section, maternal vascular perfusion nosology committee. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 7 (2004) 237-249
12. Wentworth P. The incidence and significance of intervillous thrombi in the human placenta. J Obstet Gynaecol Br Commonw 71 (1964) 894-898
13. Wilkins H.L. Unexplained elevated maternal serum alpha-fetoprotein: what is the appropriate follow-up?. Curr Opin Obstet Gynecol 10 (1998) 469-474
14. Konachuk P.S., Bernstein I.M., and Capelen E.L. Uterine artery Doppler velocimetry in the detection of adverse outcomes in women with unexplained elevated maternal serum a-fetoprotein levels. Am J Obstet Gynecol 173 (1995) 1115-1119
15. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol 113 (2009) 1405-1413
16. Arias F., Romero R., Joist H., and Kraus F.T. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 7 (1998) 277-286
17. Salafia C.M., Silberman C., Herrerra N.E., and Mahoney M.J. Placental pathology at term associated with elevated midtrimester maternal serum AFP concentration. Am J Obstet Gynecol 158 (1988) 1064-1066
18. Perkes E.A., Baim R.S., Goodman K.J., and Macri J.N. Second-trimester placental changes associated with elevated maternal serum alpha-fetoprotein. Am J Obstet Gynecol 44 (1982) 935-938
19. Nelson L.H., Bensen J., and Burton B.K. Outcomes in patients with unusually high maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol 157 (1987) 572-576
20. Lieppman R.E., Williams M.A., Cheng E.Y., Resta R., Zingheim M.N., Hickok D.E., et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 168 (1993) 1852-1857
21. Fox H. The effect of hypoxia on trophoblast in organ culture: a morphologic and autoradiologic study. Am J Obstet Gynecol 107 (1970) 1058-1064
22. Zhang P., Schmidt M., and Cook L. Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation. Am J Obstet Gynecol 194 (2006) 1050-1056
23. Fox H., and Elston C.W. Pathology of the placenta. In: Bennington J.L. (Ed). The placenta in abnormalities and disorders of the fetus (1978), WB Saunders, London 248-251
24. Jauniaux E., Gulbis B., Tunkel S., Ramsay B., Campbell S., and Meuris S. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high risk pregnancies. Prenat Diagn 16 (1996) 1129-1135
25. Mikic T.S., and Johnson P. Second trimester maternal serum beta human chorionic gonadotrophin and pregnancy outcome. BJOG 106 (1999) 598-600
26. Huerta-Enochian G., Katz V., and Erfurth S. The association of abnormal alphafetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?. Am J Obstet Gynecol 184 (2001) 1549-1553
27. Burton B.K. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 72 (1988) 709-713
28. Konachuk P.S., Bernstein I.M., and Capelen E.L. Uterine artery Doppler velocimetry in the detection of adverse outcomes in women with unexplained elevated maternal serum a-fetoprotein levels. Am J Obstet Gynecol 173 (1995) 1115-1119